CDH1 and RHOA are more prevalent among GS tumors versus TP53 which is more common in CIN tumors.27 The receptor tyrosine kinase (RTK)-RAS pathway alterations are more prevalent amongst CIN GECs. Here, TP53 is linked to cervical squamous intraepithelial neoplasia.